XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Narrative (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 25, 2022
Dec. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation expense, capitalized $ 0    
Number of shares available for grant (in shares) 1,542,375    
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted (in shares) 998,777    
Weighted average grant date fair value (in usd per share) $ 32.66    
Recognized expense $ 4,790,000 $ 3,043,000  
Total unrecognized compensation cost, RSAs $ 37,653,000    
Weighted average remaining term (in years) 2 years 10 months 24 days    
Time , Market, And Performance Based Grants | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 5 years    
Time-based      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted (in shares) 197,345    
Weighted average grant date fair value (in usd per share) $ 32.55    
Total unrecognized compensation cost, RSAs $ 13,865,000    
Weighted average remaining term (in years) 2 years 7 months 6 days    
Performance-based      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted (in shares) 713,490    
Weighted average grant date fair value (in usd per share) $ 33.16    
Total unrecognized compensation cost, RSAs $ 23,788,000    
Weighted average remaining term (in years) 3 years    
Stock options and warrants      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Recognized expense $ 544,000 $ 0  
Share-based payment award, vested in period, fair value $ 906,000   $ 362,000
Stock options and warrants | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 4 years